Disease/Infection News

RSS

Study aims to address the effects of Covid-19 on pregnant women's placenta and fetus

Addressing the risks that Covid-19 infection may cause to a pregnant woman, particularly to placenta and fetus, is the aim of a new study of the R&D&I group "Maternal-fetal medicine, epigenetics, women's diseases and reproductive health" of the Biomedical Research Institute of Malaga, which received EUR 10,000 funding from the American pharmaceutical company "FERRING".

15 Sep 2020

Sex and gender not receiving enough attention in COVID-19 trials

Researchers in Denmark and the Netherlands have conducted a study showing that sex and gender are not being adequately considered in clinical trials investigating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the coronavirus disease 2019 (COVID-19) pandemic.

15 Sep 2020

Climate change could shift the spread of West Nile virus

West Nile virus spreads most efficiently in the US at temperatures between 24-25 degrees Celsius (75.2-77 degrees Fahrenheit), a new study published today in eLife shows.

15 Sep 2020

Patients with more severe SARS-CoV-2 infection exhibit larger antibody response

Researchers in the United States have found that individuals who develop more severe disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mount a larger antibody and memory B cell response during both acute infection and convalescence.

15 Sep 2020

African swine fever does not pose health risks to humans

The ASF pathogen is a virus which infects domestic pigs and wild boar and which leads to a severe, often lethal, disease in these animals. It is transferred via direct contact or with excretions from infected animals, or through ticks.

15 Sep 2020

Study reveals damaging role of immune system in severe brain infection

A new study has detailed the damaging role played by the immune system in a severe brain condition most commonly caused by the cold sore virus.

15 Sep 2020

Simple online tool predicts rehospitalization and death risks for sepsis survivors

A tool to predict the risk of readmission to hospital or death in the first year after leaving hospital for adult survivors of sepsis has been developed by a researcher at King’s.

15 Sep 2020

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their medicine as prescribed, say Henry Ford Health System dermatology researchers in a study published in the Journal of the American Academy of Dermatology.

15 Sep 2020

COVID exodus fills vacation towns with new medical pressures

The staff at Stony Brook Southampton Hospital is accustomed to the number of patients tripling or even quadrupling each summer when wealthy Manhattanites flee the city for the Hamptons. But this year, the COVID pandemic has upended everything.

15 Sep 2020

Human activities are more likely to promote disease-spreading mosquitoes

Disease-spreading mosquitoes may be more likely to occupy areas impacted by human activities like pesticide use and habitat destruction, than they are areas less disturbed by humans, a recent Oregon State University study found.

15 Sep 2020

Loss of taste in COVID-19 is highly variable by geographic region

Even as the COVID-19 pandemic spreads in different parts of the world, scientists are still attempting to define the characteristic signs and symptoms that are useful in diagnosing the disease. This is essential knowledge to help contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Especially when it comes to diagnosing symptomatic or mild cases of COVID-19, such research could hold the key to identifying more people and preventing viral spread.

15 Sep 2020

New antibody assay for COVID-19 promises sensitive mass-scale detection

A new paper by researchers at McMaster University and Hamilton Health Sciences, published on the preprint server medRxiv in September 2020, reports on the development of a serologic assay that is suitable for sensitive high-throughput antibody testing for COVID-19.

15 Sep 2020